Bullish option flow detected in Apellis Pharmaceuticals with 1,179 calls trading, 1.3x expected, and implied vol increasing over 1 point to 59.16%. May-23 90 calls and Apr-23 80 calls are the most active options, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 0.01. Earnings are expected on May 3rd.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on APLS:
- Apellis announces validation for four marketing applications for pegcetacoplan
- Apellis Announces Validation of Four Marketing Applications for Pegcetacoplan for Geographic Atrophy
- These 2 Red-Hot Stocks Could Reach New Highs, Says Goldman Sachs
- Apellis partners with Henry Winkler to raise awareness of GA
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
